CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment	$ 235,640
Common Stock And Warrants
Sale of stock expense	$ 97,260	$ 1,336,123
Series B Convertible Preferred Stock
Sale of stock expense		$ 497,617